GemVax & KAEL Co Ltd
KOSDAQ:082270
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
G
|
GemVax & KAEL Co Ltd
KOSDAQ:082270
|
1.7T KRW |
Loading...
|
|
| NL |
|
ASML Holding NV
AEX:ASML
|
458.8B EUR |
Loading...
|
|
| US |
|
Lam Research Corp
NASDAQ:LRCX
|
291.1B USD |
Loading...
|
|
| US |
|
Applied Materials Inc
NASDAQ:AMAT
|
261.7B USD |
Loading...
|
|
| US |
B
|
Brooks Automation Inc
LSE:0HQ1
|
258.3B USD |
Loading...
|
|
| US |
|
KLA Corp
NASDAQ:KLAC
|
192.1B USD |
Loading...
|
|
| JP |
|
Advantest Corp
TSE:6857
|
19.5T JPY |
Loading...
|
|
| JP |
|
Tokyo Electron Ltd
TSE:8035
|
18.9T JPY |
Loading...
|
|
| JP |
|
Disco Corp
TSE:6146
|
7.9T JPY |
Loading...
|
|
| CN |
|
NAURA Technology Group Co Ltd
SZSE:002371
|
351.9B CNY |
Loading...
|
|
| US |
|
Teradyne Inc
NASDAQ:TER
|
48.6B USD |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
GemVax & KAEL Co Ltd
Glance View
GemVax & KAEL Co., Ltd. engages in the production of chemical filters and gas scrubbers for semiconductors. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2005-06-24. The firm and its subsidiaries are engaged in the three categories of businesses: pollution control business, which manufactures chemical air (CA) filters, gas scrubbers, resins, coating resins and other environmental equipments and systems; anticancer and anti-inflammation business, which engages in development of cancer vaccines for infectious diseases, such as acquired immune deficiency syndrome (AIDS) and anti-inflammations, and IT business which mainly produces liquid crystal display (LCD) modules. The firm distributes its products within domestic market and to overseas markets.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for GemVax & KAEL Co Ltd is 35.1%, which is above its 3-year median of 33.3%.
Over the last 3 years, GemVax & KAEL Co Ltd’s Gross Margin has increased from 29.3% to 35.1%. During this period, it reached a low of 26.6% on Mar 31, 2023 and a high of 39.2% on Mar 31, 2024.
